Skip to main content
. 2021 Mar 3;132:104304. doi: 10.1016/j.compbiomed.2021.104304

Table 3.

Descriptive statistics (frequency and percent) of discrete (categorical) clinical features in the training/validation and test sets.

Categorical Features Training/Validation (frequency in %) Test (frequency in %) p-value
Gender F 37 (34.6%) 28 (62.2%) 0.15
M 70 (65.4%) 17 (37.8%)
ground-glass opacities (GGO) 0 4 (3.74%) 0 1.00
1 49 (45.8%) 21 (46.7%)
2 54 (50.5%) 24 (53.3%)
Consolidation 0 7 (6.54%) 7 (15.6%) 1.00
1 53 (49.5%) 13 (28.9%)
2 47 (43.9%) 25 (55.6%)
Reticular 0 36 (33.6%) 12 (26.7%) 0.58
1 51 (47.7%) 25 (55.6%)
2 20 (18.7%) 8 (17.8%)
Axial Distribution)Ax.Dist( 1 61 (57%) 23 (51.1%) 0.74
2 2 (1.87%) 1 (2.22%)
3 44 (41.1%) 21 (46.7%)
Coronal Distribution (CC.Dist) 1 4 (3.74%) 2 (4.44%) 0.37
2 36 (33.6%) 16 (35.6%)
3 67 (62.6%) 27 (60%)
Number of Involved Zones (Num.Zones.Involved) 1 3 (2.8%) 1 (2.22%) 0.79
2 9 (8.41%) 3 (6.67%)
3 6 (5.61%) 4 (8.89%)
4 9 (8.41%) 5 (11.1%)
5 20 (18.7%) 5 (11.1%)
6 60 (56.1%) 27 (60%)
Pleural Effusion (Pleural.Eff) 0 78 (72.9%) 36 (80%) 0.46
1 29 (27.1%) 9 (20%)
Pericardial Effusion (Pericardial.Eff) 0 88 (82.2%) 37 (82.2%) 1.00
1 19 (17.8%) 8 (17.8%)
Emphysema 0 79 (73.8%) 34 (75.6%) 0.61
1 28 (26.2%) 11 (24.4%)
Cardiomegaly 0 49 (45.8%) 22 (48.9%) 1.00
1 58 (54.2%) 23 (51.1%)
Diabetes 0 76 (71%) 35 (77.8%) 0.50
1 31 (29%) 10 (22.2%)
Hypertension) HTN ( 0 71 (66.4%) 28 (62.2%) 1.00
1 36 (33.6%) 17 (37.8%)
Ischemic Heart Disease) IHD ( 0 82 (76.6%) 37 (82.2%) 1.00
1 25 (23.4%) 8 (17.8%)
Cancerous 0 95 (88.8%) 42 (93.3%) 0.75
1 12 (11.2%) 3 (6.67%)
Smoking 1 94 (87.85%) 39 (86.67%) 0.55
2 9 (8.41%) 4 (8.89%)
3 4 (3.74%) 2 (4.44%)
Consciousness 0 2 (1.87%) 0 0.46
1 1 (0.935%) 1 (2.22%)
2 9 (8.41%) 4 (8.89%)
3 95 (88.8%) 40 (88.89%)
Mixed 0 50 (46.7%) 30 (66.7%) 0.57
1 57 (53.3%) 15 (33.3%)